Cathy Eng, MD, FACP, FASCO, Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center. She also holds the David H. Johnson Endowed Chair of Surgical and Medical Oncology. Dr. Eng was previously a Professor of Medical Oncology at The University of Texas MD Anderson Cancer Center.

Her primary clinical research interests include clinical trials involving innovative drugs for the treatment of colorectal, anal, and appendiceal cancers. She has a specific interest in young colorectal cancer patients as well as the role of immunotherapy in HPV-associated cancers. She has published multiple publications in these GI malignancies. Dr. Eng currently has over 200 publications.

Nationally, Dr. Eng has served in multiple leadership roles for ASCO, ASCO GI, ECOG, and the NCI Rectal/Anal Task Force. She has most recently been chosen to serve as the Vice-Chair for the SWOG GI Committee and the NCI GI Steering Committee.

Cathy Eng MD FACP FASCO
David H. Johnson Chair in Surgical and Medical Oncology
Co-Leader, Gastrointestinal Cancer Research Program
Professor of Medicine (Hematology and Oncology)
Co-Director, GI Oncology
Vice-Chair, SWOG GI Committee
Director, VICC Young Adult Cancers Initiative
Professor of Medicine, Hematology & Oncology at Vanderbilt Health.